Drotrecogin alfa (activated): current evidence supports treatment for severe sepsis patients with a high risk of death.
Williams
Mark D
MD
Janes
Jonathan M
JM
Nelson
David R
DR
D018806:APACHE; D006801:Humans; D011486:Protein C / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000627:therapeutic use; D012307:Risk Factors; D018805:Sepsis / Q000188:drug therapy* / Q000401:mortality*
D011486:Protein C; D011994:Recombinant Proteins; C421124:drotrecogin alfa activated